• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异烟酸酰肼类抗结核药物的作用方式及定量构效关系

Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.

作者信息

Seydel J K, Schaper K J, Wempe E, Cordes H P

出版信息

J Med Chem. 1976 Apr;19(4):483-92. doi: 10.1021/jm00226a007.

DOI:10.1021/jm00226a007
PMID:817022
Abstract

Quantitative structure-activity studies have been performed for a series of 2-substituted isonicotinic acid hydrazides by correlating electronic, steric, and lipophilic properties of the substituents with the biological activity date (MIC) from serial dilution tests with Mycobacterium tuberculosis (strain H 37 Rv). The reaction rates for the quaternization of 2-substituted pyridines with methyl iodide were also determined. The rate constants show a similar dependence on the steric and electronic effects of the substituents as the antibacterial activities of the corresponding pyridine-4-carboxylic acid hydrazides. The obtained correlations give evidence that the reactivity of the pyridine nitrogen atom is essential for the biological activity of 2-substituted isonicotinic acid hydrazides and seem to support the hypothesis that isonicotinic acid derivatives are incorporated into an NAD analogue.

摘要

通过将取代基的电子、空间和脂溶性性质与来自结核分枝杆菌(H 37 Rv菌株)系列稀释试验的生物活性数据(MIC)相关联,对一系列2-取代异烟酸酰肼进行了定量构效关系研究。还测定了2-取代吡啶与甲基碘季铵化的反应速率。速率常数对取代基的空间和电子效应的依赖性与相应吡啶-4-羧酸酰肼的抗菌活性相似。所得到的相关性证明吡啶氮原子的反应性对于2-取代异烟酸酰肼的生物活性至关重要,并且似乎支持异烟酸衍生物被并入NAD类似物的假说。

相似文献

1
Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.异烟酸酰肼类抗结核药物的作用方式及定量构效关系
J Med Chem. 1976 Apr;19(4):483-92. doi: 10.1021/jm00226a007.
2
Usefulness of graphical invariants in quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.图形不变量在异烟肼类抗结核药物定量构效关系中的应用
J Mol Model. 2004 Apr;10(2):102-11. doi: 10.1007/s00894-003-0173-6. Epub 2003 Dec 23.
3
Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.异烟肼及其衍生物的铁(II)配合物的合成及反应机理研究:一种基于氧化还原介导的抗结核治疗激活策略。
J Inorg Biochem. 2018 Feb;179:71-81. doi: 10.1016/j.jinorgbio.2017.11.013. Epub 2017 Nov 21.
4
Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.基于可再生脂肪酸的异烟肼衍生物的合成及抗分枝杆菌活性。
Bioorg Med Chem. 2013 Nov 15;21(22):6910-4. doi: 10.1016/j.bmc.2013.09.034. Epub 2013 Sep 20.
5
Novel isoniazid derivative as promising antituberculosis agent.新型异烟肼衍生物有望成为抗结核药物。
Future Microbiol. 2020 Jul;15(10):869-879. doi: 10.2217/fmb-2019-0085. Epub 2020 Jul 14.
6
Designing new antitubercular isoniazid derivatives with improved reactivity and membrane trafficking abilities.设计具有更好反应活性和膜运输能力的新型抗结核异烟肼衍生物。
Biomed Pharmacother. 2021 Dec;144:112362. doi: 10.1016/j.biopha.2021.112362. Epub 2021 Oct 26.
7
Mechanistic investigation of the oxidation of hydrazides: implications for the activation of the TB drug isoniazid.关于酰肼类化合物氧化反应的机理研究:对结核药物异烟肼的激活作用的启示。
Org Biomol Chem. 2013 Jan 7;11(1):170-6. doi: 10.1039/c2ob26419f.
8
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.具有强效抗结核活性的新型异烟肼衍生物的设计、合成及生物学评价
Eur J Med Chem. 2014 Jun 23;81:119-38. doi: 10.1016/j.ejmech.2014.04.077. Epub 2014 Apr 29.
9
Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.富勒烯异烟肼共轭物——一种亲脂性增强的抗结核药:合成及抗分枝杆菌活性评价
Chem Biol Drug Des. 2009 May;73(5):553-7. doi: 10.1111/j.1747-0285.2009.00804.x.
10
Synthesis and bioevaluation of some new isoniazid derivatives.合成及一些新异烟肼衍生物的生物评价。
Bioorg Med Chem. 2013 Sep 1;21(17):5355-61. doi: 10.1016/j.bmc.2013.06.013. Epub 2013 Jun 15.

引用本文的文献

1
Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-]pyrrole Chelators.吡咯并[3,2-f]吡咯螯合剂靶向线粒体 TET1 蛋白。
Int J Mol Sci. 2022 Sep 16;23(18):10850. doi: 10.3390/ijms231810850.
2
Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?抗生素衍生放射性示踪剂正电子发射断层扫描:核成像还是“不明”感染成像?
Angew Chem Int Ed Engl. 2022 Nov 7;61(45):e202204955. doi: 10.1002/anie.202204955. Epub 2022 Sep 20.
3
Reinvestigation of the structure-activity relationships of isoniazid.
重新研究异烟肼的结构-活性关系。
Tuberculosis (Edinb). 2021 Jul;129:102100. doi: 10.1016/j.tube.2021.102100. Epub 2021 Jun 5.
4
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against H37Rv strain.利福平与异烟肼苯腙在可生物降解聚合物纳米粒中抗 H37Rv 株的抗分枝杆菌药敏试验评价。
Int J Nanomedicine. 2018 Jul 23;13:4303-4318. doi: 10.2147/IJN.S163925. eCollection 2018.
5
Altered glycine decarboxylation inhibition in isonicotinic Acid hydrazide-resistant mutant callus lines and in regenerated plants and seed progeny.异烟肼抗性突变愈伤组织系、再生植株及种子后代中甘氨酸脱羧抑制作用的改变。
Plant Physiol. 1982 Jan;69(1):198-204. doi: 10.1104/pp.69.1.198.
6
Usefulness of graphical invariants in quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.图形不变量在异烟肼类抗结核药物定量构效关系中的应用
J Mol Model. 2004 Apr;10(2):102-11. doi: 10.1007/s00894-003-0173-6. Epub 2003 Dec 23.
7
Peroxidase-mediated oxidation of isoniazid.过氧化物酶介导的异烟肼氧化反应。
Antimicrob Agents Chemother. 1985 Mar;27(3):399-403. doi: 10.1128/AAC.27.3.399.
8
Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid.异烟肼的酶促和非酶促超氧化物生成反应。
Antimicrob Agents Chemother. 1985 Mar;27(3):408-12. doi: 10.1128/AAC.27.3.408.
9
Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra.异烟肼处理结核分枝杆菌H37Ra提取物产生活性氧的证据。
Antimicrob Agents Chemother. 1985 Mar;27(3):404-7. doi: 10.1128/AAC.27.3.404.